IRIS
PETRIOLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.438
EU - Europa 2.759
AS - Asia 641
SA - Sud America 118
AF - Africa 20
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.985
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.421
GB - Regno Unito 686
IE - Irlanda 552
IT - Italia 329
CN - Cina 328
SE - Svezia 249
RU - Federazione Russa 218
UA - Ucraina 213
SG - Singapore 195
DE - Germania 139
FR - Francia 125
BR - Brasile 97
FI - Finlandia 74
ES - Italia 42
BE - Belgio 37
VN - Vietnam 31
IN - India 25
LU - Lussemburgo 22
CA - Canada 16
CI - Costa d'Avorio 12
NL - Olanda 11
CL - Cile 10
IR - Iran 9
CZ - Repubblica Ceca 8
PL - Polonia 8
AR - Argentina 7
AT - Austria 7
BD - Bangladesh 7
HK - Hong Kong 7
TR - Turchia 7
AU - Australia 6
LT - Lituania 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CH - Svizzera 4
AZ - Azerbaigian 3
DK - Danimarca 3
LV - Lettonia 3
NO - Norvegia 3
PK - Pakistan 3
AL - Albania 2
DZ - Algeria 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
IQ - Iraq 2
JO - Giordania 2
JP - Giappone 2
KG - Kirghizistan 2
KR - Corea 2
KZ - Kazakistan 2
MA - Marocco 2
MW - Malawi 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
ID - Indonesia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
Totale 6.985
Salva come PNG Salva come JPEG
Città #
Southend 629
Dublin 547
Fairfield 535
Ashburn 270
Woodbridge 250
Chandler 227
Santa Clara 212
Ann Arbor 211
Wilmington 197
Cambridge 188
Seattle 183
Jacksonville 179
Houston 168
Princeton 89
Siena 86
Singapore 79
New York 65
Beijing 60
Nanjing 56
Shanghai 44
Helsinki 39
San Mateo 39
Brussels 37
Málaga 36
Boardman 30
Dong Ket 29
Milan 28
Munich 26
San Diego 26
Los Angeles 25
Shenyang 22
Dallas 21
The Dalles 21
Moscow 20
Nanchang 18
Jiaxing 15
Rome 15
Council Bluffs 14
Florence 14
Roodt-sur-Syre 14
London 13
Abidjan 12
Hebei 10
Venezia 10
Düsseldorf 9
Nuremberg 9
Zhengzhou 9
Arezzo 8
Kunming 8
Lauterbourg 8
Portsmouth 8
San Francisco 8
Santiago 8
São Paulo 8
Toronto 8
Hong Kong 7
Tianjin 7
Aosta 6
Changsha 6
Dearborn 6
Fremont 6
Guangzhou 6
Norwalk 6
Redwood City 6
Washington 6
Zanjan 6
Belo Horizonte 5
Brno 5
Elk Grove Village 5
Lublin 5
Ningbo 5
North Bergen 5
Taizhou 5
Tappahannock 5
Viareggio 5
Vijayawada 5
Colle di Val d'Elsa 4
Frankfurt am Main 4
Hangzhou 4
Jinan 4
Leawood 4
Luxembourg 4
Ottawa 4
São José 4
Baku 3
Bangalore 3
Dhaka 3
Lastra a Signa 3
Livorno 3
Madrid 3
Narni 3
New Bedfont 3
Riga 3
Santa Maria Capua Vetere 3
Sydney 3
Vienna 3
Winnipeg 3
Zurich 3
Alessandria 2
Amman 2
Totale 5.096
Salva come PNG Salva come JPEG
Nome #
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy 236
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 216
C-Met targeting in advanced gastric cancer: An open challenge 212
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 192
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 189
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 188
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 185
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 167
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 166
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 161
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab 159
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results 155
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 155
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 155
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients 155
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status 148
Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases 146
Gastric cancer: Current status of lymph node dissection 146
Signet ring cell percentage in poorly cohesive gastric cancer patients: a potential novel predictor of survival 143
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials 135
Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer 135
Short-term and long-term risk factors in gastric cancer 129
A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer 126
GEMCITABINE (dFdC), 5-FLUROURACIL (5FU), AND FOLINIC ACID (FA) IN THE TREATMENT OF PATIENTS WITH GASTRO-ENTERIC CARCINOMAS: A CLINICAL AND PHARMACOLOGICAL STUDY. 120
Treatment of bone metastases with dichloromethylene bisphosphonate 115
Hyperprogressive disease in advanced cancer patients treated with nivolumab: a case series study 115
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer 115
null 112
null 112
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study: TILs for ADJ-untreated stage II colon cancer 111
null 110
null 109
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient 104
null 103
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer 102
null 98
null 98
null 96
null 96
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: A meta-analysis of four randomized trials 91
null 89
Preoperative or perioperative docetaxel, oxaliplatin, and capecitabine (GASTRODOC regimen) in patients with locally-advanced resectable gastric cancer: a randomized phase-II trial 89
null 88
null 87
The percentage of signet ring cells is inversely related to aggressive behavior and poor prognosis in mixed-type gastric cancer 80
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report 79
Squamous cell carcinoma of the maxillary sinus: A retrospective analysis of 36 cases 71
An exceptional overall survival using bevacizumab beyond progression in a patient with Non-small cell lung cancer 71
Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM) 69
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer 66
Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis 65
Association of Concomitant Bone Resorption Inhibitors with Overall Survival among Patients with Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate with Prednisone as First-Line Therapy 65
Clinical value and impact on prognosis of peri-operative CA 19-9 serum levels in stage I and II adenocarcinoma of the pancreas 64
Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence 60
Five years of stable disease with maintenance therapy using bevacizumab and tamoxifen in a patient with metastatic breast cancer 57
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate 56
Thymostimulin in Association with Chemotherapy in Breast Cancer Patients with Bone Metastases 53
Specific clonal expansion at disease progression (PD) in solid cancers pinpointed by cell free DNA analysis 51
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience. 48
Cytoreduction surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as treatment choice of metastatic Urachal carcinoma 44
Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer. 42
Surgical management of advanced gastric cancer: An evolving issue 42
Posterior and Para-Aortic (D2plus) Lymphadenectomy after Neoadjuvant/Conversion Therapy for Locally Advanced/Oligometastatic Gastric Cancer 40
null 39
Neuroendocrine tumors' patients treated with somatostatin analogue could complicate with emergency cholecystectomy 30
Totale 7.151
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.142
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020152 0 0 0 0 0 0 0 0 0 0 51 101
2020/20211.137 48 114 48 108 69 114 69 178 87 134 85 83
2021/2022717 57 63 50 45 30 38 32 32 34 72 97 167
2022/2023958 56 69 138 107 85 203 31 78 96 46 26 23
2023/2024908 33 16 87 45 27 234 306 9 0 45 48 58
2024/20251.175 63 95 163 116 225 109 33 93 167 54 57 0
Totale 7.151